Aberrant methylation at the KEAP1 promoter was firstly described in human NSCLC cell lines and tissues and involves the CpGs grouped into one main island located near the transcriptional start site (TSS) [14]. Here, KEAP1 is linked to non-small cell lung carcinoma.